Primaquine for plasmodium vivax malaria treatment – authors' reply
Váldodahkkit: | Price, RN, Taylor, WRJ, Thriemer, K, White, NJ, Day, NP |
---|---|
Materiálatiipa: | Journal article |
Giella: | English |
Almmustuhtton: |
Elsevier
2020
|
Geahča maid
-
Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
Dahkki: Setyadi, A, et al.
Almmustuhtton: (2019) -
Higher-dose primaquine to prevent relapse of Plasmodium vivax malaria
Dahkki: Watson, JA, et al.
Almmustuhtton: (2022) -
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
Dahkki: Taylor, WRJ, et al.
Almmustuhtton: (2023) -
The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
Dahkki: Thriemer, K, et al.
Almmustuhtton: (2020) -
Treatment of primaquine-resistant Plasmodium vivax malaria.
Dahkki: Luzzi, G, et al.
Almmustuhtton: (1992)